FDA
Health
Pfizer Granted Priority Review for FDA Vaccine Approval
Last Friday, the US FDA granted pharmaceutical companies Pfizer and BioNTech priority review designation for their coronavirus vaccine.
Greek News
Moderna Says Vaccine Safe for Teens, Will Submit to FDA
The Moderna pharmaceutical company announced on Tuesday that its mRNA vaccine, now only given to adults, is highly effective in adolescents.
Greece
Coronavirus Cases, Intubations See Steep Rise in Greece
The number of coronavirus cases diagnosed in Greece in the last 24 hours saw a sharp increase, along with those undergoing intubation.
Greek News
FDA Approves Use of Pfizer’s Covid-19 Vaccine in Children Aged 12-15
Children aged 12 to 15 can receive Pfizer's Covid-19 vaccine, the United States’ Food and Drug Administration announced on Monday.
Greek News
US Pivots, Distributing Vaccine According to Demand — Not Population
The White House announced Tuesday that it will distribute coronavirus vaccines according to demand, marking a shift in vaccine distribution.
Health
US May Authorize Pfizer Vaccine For Children By Next Week
The United States may authorize Pfizer's vaccine for children aged 12 to 15 as soon as next week, CEO Albert Bourla said on Tuesday.
Greek News
FDA Calls for Halt to Administration of Johnson & Johnson Vaccine
The USFDA called for a halt to federally-sponsored inoculation campaigns using the Johnson & Johnson vaccine.
Europe
EU Drug Regulators Say AstraZeneca Vaccine Benefits Outweigh Risks
The EMA said that the benefits of the AstraZeneca vaccine still outweigh any potential risk of blood clot formation.
Greek news
Johnson & Johnson Sends New Vaccine to FDA For Approval
The American Food and Drug Administration will begin to review the Johnson & Johnson vaccine, which the company states is 100% effective at preventing hospitalizations and deaths from Covid-19, on February 26.
The Johnson & Johnson product -- in contrast...
Greek News
Moderna Vaccine Gets OK from FDA; EU to Receive 160 Million Doses
The coronavirus vaccine developed by the American pharmaceutical firm Moderna, based in Cambridge, Massachusetts, along with the National Institute of Allergy and Infectious Diseases (NIAID) was cleared by the FDA on Friday after receiving the all-important thumbs-up from its independent...